GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » NovoCure Ltd (FRA:038) » Definitions » E10

NovoCure (FRA:038) E10 : €-1.03 (As of Dec. 2024)


View and export this data going back to 2015. Start your Free Trial

What is NovoCure E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

NovoCure's adjusted earnings per share data for the three months ended in Dec. 2024 was €-0.583. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-1.03 for the trailing ten years ended in Dec. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2025-03-16), NovoCure's current stock price is €17.83. NovoCure's E10 for the quarter that ended in Dec. 2024 was €-1.03. NovoCure's Shiller PE Ratio of today is .


NovoCure E10 Historical Data

The historical data trend for NovoCure's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NovoCure E10 Chart

NovoCure Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.95 -1.03

NovoCure Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.95 -0.94 -1.00 -0.93 -1.03

Competitive Comparison of NovoCure's E10

For the Medical Devices subindustry, NovoCure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NovoCure's Shiller PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, NovoCure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where NovoCure's Shiller PE Ratio falls into.



NovoCure E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, NovoCure's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=-0.583/133.1571*133.1571
=-0.583

Current CPI (Dec. 2024) = 133.1571.

NovoCure Quarterly Data

per share eps CPI Adj_EPS
201503 -0.298 99.621 -0.398
201506 -0.316 100.684 -0.418
201509 -0.280 100.392 -0.371
201512 -0.361 99.792 -0.482
201603 -0.377 100.470 -0.500
201606 -0.427 101.688 -0.559
201609 -0.347 101.861 -0.454
201612 -0.246 101.863 -0.322
201703 -0.196 102.862 -0.254
201706 -0.214 103.349 -0.276
201709 -0.109 104.136 -0.139
201712 -0.101 104.011 -0.129
201803 -0.187 105.290 -0.236
201806 -0.146 106.317 -0.183
201809 -0.111 106.507 -0.139
201812 -0.149 105.998 -0.187
201903 -0.115 107.251 -0.143
201906 -0.009 108.070 -0.011
201909 0.018 108.329 0.022
201912 0.036 108.420 0.044
202003 0.036 108.902 0.044
202006 0.018 108.767 0.022
202009 0.076 109.815 0.092
202012 0.033 109.897 0.040
202103 -0.034 111.754 -0.041
202106 -0.116 114.631 -0.135
202109 -0.111 115.734 -0.128
202112 -0.221 117.630 -0.250
202203 -0.036 121.301 -0.040
202206 -0.218 125.017 -0.232
202209 -0.253 125.227 -0.269
202212 -0.340 125.222 -0.362
202303 -0.467 127.348 -0.488
202306 -0.498 128.729 -0.515
202309 -0.431 129.860 -0.442
202312 -0.413 129.419 -0.425
202403 -0.331 131.776 -0.334
202406 -0.288 132.554 -0.289
202409 -0.252 133.029 -0.252
202412 -0.583 133.157 -0.583

Add all the adjusted EPS together and divide 10 will get our e10.


NovoCure  (FRA:038) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


NovoCure E10 Related Terms

Thank you for viewing the detailed overview of NovoCure's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


NovoCure Business Description

Traded in Other Exchanges
Address
Grenville Street, No. 4 The Forum, Second Floor, St. Helier, JEY, JE2 4UF
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.

NovoCure Headlines

No Headlines